Of all tested biomarkers, AFP performed best for the detection of early HCC at a cut-off of 20 ng/mL (AUC: 0.678, sensitivity: 45.2%, specificity: 90.2%). This evidence concerns the gene AFP and hepatocellular carcinoma.